REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,440,158 | -8.0% | 88,156 | -11.1% | 0.00% | 0.0% |
| Q2 2023 | $2,651,835 | +21.3% | 99,134 | -1.8% | 0.00% | +33.3% |
| Q1 2023 | $2,186,859 | +10.0% | 100,963 | +21.0% | 0.00% | 0.0% |
| Q4 2022 | $1,988,255 | +24.4% | 83,470 | +3.0% | 0.00% | 0.0% |
| Q3 2022 | $1,598,000 | +27.0% | 81,052 | +25.5% | 0.00% | +50.0% |
| Q2 2022 | $1,258,000 | -25.7% | 64,561 | -2.8% | 0.00% | 0.0% |
| Q1 2022 | $1,694,000 | -7.8% | 66,421 | -9.0% | 0.00% | 0.0% |
| Q4 2021 | $1,837,000 | -6.1% | 72,996 | +2.6% | 0.00% | -33.3% |
| Q3 2021 | $1,956,000 | -24.7% | 71,114 | -13.1% | 0.00% | 0.0% |
| Q2 2021 | $2,598,000 | -12.1% | 81,855 | +27.1% | 0.00% | -25.0% |
| Q1 2021 | $2,956,000 | +27.1% | 64,427 | +9.7% | 0.00% | +33.3% |
| Q4 2020 | $2,325,000 | +14.4% | 58,739 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $2,032,000 | +199.7% | 58,384 | +172.0% | 0.00% | +200.0% |
| Q2 2020 | $678,000 | +44.3% | 21,466 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $470,000 | – | 21,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |